chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 25.0
Sex: F
Vaccine: HPV4
Symptoms: Electrocardiogram normal, Hypoaesthesia, Influenza like illness, Injection site pain, Laboratory test
Clinical narrative: Information has been received from a Registered Nurse concerning a 25 year old female patient with no pertinent medical history and no drug reactions or allergies who on 15-MAY-2009 was vaccinated with a first dose of GARDASIL (Lot # 658271/0558X) 0.5ml intramuscularly in the upper left arm. Concomitant therapy included SEASONALE. On 16-MAY-2009 the patient experienced severe arm pain and soreness from the injection site and down the arm. There was slight numbness. On 15-MAY-2009 pregnancy test was performed and was negative. On 19-MAY-2009 the patient went to the emergency room for flu like symptoms and the arm pain. She was given TORADOL for pain. On 20-MAY-2009 the patient recovered. Follow up information from a certified medical assistant revealed that the patient received no other vaccines at the time of the GARDASIL. The patient went to the Urgent Care Center on 19-MAY-2009. Charts showed EKG and lab work done there were normal. Additional information is not expected.
Age: 25.0
Sex: F
Vaccine: HPV4
Symptoms: Pain in extremity, Pregnancy test negative
Clinical narrative: Information has been received from a Registered Nurse concerning a 25 year old female patient with no pertinent medical history and no drug reactions or allergies who on 15-MAY-2009 was vaccinated with a first dose of GARDASIL (Lot # 658271/0558X) 0.5ml intramuscularly in the upper left arm. Concomitant therapy included SEASONALE. On 16-MAY-2009 the patient experienced severe arm pain and soreness from the injection site and down the arm. There was slight numbness. On 15-MAY-2009 pregnancy test was performed and was negative. On 19-MAY-2009 the patient went to the emergency room for flu like symptoms and the arm pain. She was given TORADOL for pain. On 20-MAY-2009 the patient recovered. Follow up information from a certified medical assistant revealed that the patient received no other vaccines at the time of the GARDASIL. The patient went to the Urgent Care Center on 19-MAY-2009. Charts showed EKG and lab work done there were normal. Additional information is not expected.
Age: 14.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Dizziness, Helicobacter infection
Clinical narrative: Information has been received from a physician concerning a "14 year" old female patient who was hospitalized couple days for "Helicobacter pylori". On unspecified day she received second dose of GARDASIL (Lot # not reported). Concomitant therapy included VARIVAX and NEXIUM. After got the vaccine the patient felt like fainting. The patient sought unspecified medical attention. At the time of the report on 27-MAY-2009 the patient had recovered. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Headache, Injection site pain, Nausea, Vomiting
Clinical narrative: Information has been received from an emergency medical technician concerning a 15 year old female patient with no drug reactions or allergies who on approximately 20-MAY-2009 had a yeast infection.  On 21-MAY-2009 she received a dose of GARDASIL (lot # not reported) intramuscularly.  Concomitant therapy included SERTRALINE HC1.  On 21-MAY-2009 the patient developed nausea, headache and vomiting.  The patient also complained of soreness at site of injection.  At the time of the report on 27-MAY-2009 the patient had not recovered.  The patient sought medical attention called the office.  There were no laboratories diagnostics performed.  Additional information has been requested. 6/22/09 Medical records received DOS 5/12/09 to 6/3/09. Patient presents with soreness at injection site, headaches, nausea and vomiting. At time of immunization was being treated with Diflucan for candidiasis of vulva and vagina.
Sex: F
Vaccine: HPV4
Symptoms: Optic neuritis
Clinical narrative: Information has been received from a physician concerning a female who was vaccinated with a dose of GARDASIL. One or two months after the GARDASIL dose the patient experienced optic neuritis. This is one of two reports from the same source. Additional information is not expected.
Sex: F
Vaccine: HPV4
Symptoms: Headache, Injection site pain, Vaccine positive rechallenge, Vision blurred
Clinical narrative: Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with the first dose of GARDASIL vaccine. On 22-MAY-2009, the patient was vaccinated with the second dose of GARDASIL vaccine. After receiving the first dose, the patient experienced pain at the injection site and then was fine. After receiving the second dose, the patient experienced arm pain at the injection site which went up her arm and started to have pain in her head and then when she looked to that side of the head her vision was blurry. The patient called the physician and the physician told the patient "if the symptoms were still occurring or get worse she should call the office back". At the time of reporting, the patient had not recovered. Additional information has been requested. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Information has been received from a nurse concerning a 23 year old female patient who on 20-MAY-2009 was vaccinated with a second dose of GARDASIL (Lot # 0294Y). On 26-MAY-2009 she could hardly move her arm due to pain. On 27-MAY-2009 the patient went to the physician and he stated there was no cellulitis. At the time on the report on 27-MAY-2009 the patient had not recovered. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Drug exposure during pregnancy, Injection site pain, Pregnancy test positive
Clinical narrative: Information has been received from a consumer, for the Pregnancy Registry for GARDASIL, concerning her 15 year old daughter with seasonal allergy who on 22-OCT-2008, on 29-DEC-2008 and on 22-APR-2009 was vaccinated with a first, second and third dose respectively, of GARDASIL (routes and lot numbers not reported). Concomitant medication were unspecified. The mother reported that on 1-MAY-2009, the patient conducted a home urine pregnancy test and it came up positive. The patient went to see her physician and the physician conducted a urine pregnancy test and the result came back positive again (LMP: 26-MAR-2009, EDD: 31-DEC-2009). The mother added the patient mentioned that after receiving the second and third dose of GARDASIL, the patient experienced soreness on the injection sight. Also the mother reported the patient is fine now. The patient sought medical attention at the physician's office. No further information provide. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Nervousness, Syncope
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a female who on 27-MAY-2009 was vaccinated with a dose of GARDASIL (LOT# not reported). It was unknown which dose in the series the patient received. On 27-MAY-2009, since vaccination, the patient fainted after receiving the vaccination. The nurse did not think the fainting was related to the vaccine and stated, "thought the patient was nervous and skittish about shots". It was reported that the patient sought medical attention in the office. The patient's outcome was unknown. Follow-up information has been received from via a phone call from the registered nurse (R.N.) concerning a female who on months ago was vaccinated with the first dose of GARDASIL (LOT# not reported). The registered nurse said the patient was fine. The mother reported that the patient usually dose this when she gives blood or gets shots. The registered nurse (R.N.) contacted during telephone follow-up could not supply the following information: patient name, date of birth, lot number, date of event and recovery status. No further information is available at this time.
Sex: F
Vaccine: HPV4
Symptoms: Rash
Clinical narrative: Information has been received from another physician (not the patient's physician) concerning a female who was vaccinated with a dose of GARDASIL (Lot # was not available). The patient experienced a "rash like bumps after receiving GARDASIL". The patient was seen by the physician to seek medical attention. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Orthostatic hypotension
Clinical narrative: Information has been received from a physician concerning four female patients who were vaccinated with doses of GARDASIL vaccine. Subsequently the patients experienced postural hypotension. Unspecified medical attention was sought. At the time of this report, the outcomes were unknown. Follow up information was received from a physician on 26-MAY-2009. The patient was the nurse's daughter. The physician stated that after further discussions, it was decided that there was no relation to these events and the GARDASIL vaccination. The physician was confident that the patient was fine. This is one of several cases from the same source. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Orthostatic hypotension
Clinical narrative: Information has been received from a physician concerning four female patients who were vaccinated with doses of GARDASIL. Subsequently the patients experienced postural hypotension. Unspecified medical attention was sought. At the time of this report, the outcomes were unknown. Follow up information was received from a physician on 26-MAY-2009. The patient was the pharmacist's daughter. The physician stated that after further discussions, it was decided that there was no relation to these events and the GARDASIL vaccination. The physician was confident that the patient was fine. This is one of several cases from the same source. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Orthostatic hypotension
Clinical narrative: Information has been received from a physician concerning four female patients who were vaccinated with doses of GARDASIL. Subsequently the patients experienced postural hypotension. Unspecified medical attention was sought. At the time of this report, the outcomes were unknown. Follow up information was received from a physician concerning a female patient. The physician stated that after further discussions, it was decided that there was no relation to these events and the GARDASIL vaccination. The physician was confident that the patient was fine. This is one of several cases from the same source. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Chills, Immediate post-injection reaction, Myalgia
Clinical narrative: Information has been received from a nurse through a representative concerning a female patient who was vaccinated with the first dose of GARDASIL. Subsequently the patient experienced immediate reactions including chills and muscle pain, The muscle pain lasted for about 2 weeks. It was unknown if the patient sought medical attention. At the time of report the patient recovered from chills and muscle pain. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a medical assistant concerning a female patient who was vaccinated with the first dose of GARDASIL and had fainted. Unspecified medical attention had been sought. The patient recovered. This is one of several reports received from the same source. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Local swelling
Clinical narrative: Information has been received from a nurse practitioner concerning a 11 year old female who on 19-MAY-2009 was vaccinated with her first dose of GARDASIL (Lot#661841/0653X). The concomitant medication was not reported. On 28-MAY-2009 the patient noticed after showering that her neck was swollen. It just suddenly popped up on the clavicular region within an hour's time frame. it was unknown whether the patient sought medical attention. The outcome was unknown at the report time. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Injection site pain
Clinical narrative: Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a dose of GARDASIL (LOT# not reported). Subsequently the patient experienced injection site pain. The physician did not see the patient himself and he heard this through a pediatric colleague. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Urticaria
Clinical narrative: Information has been received from a Nurse Practitioner concerning a female about 14 years old who was vaccinated with the first 0.5 mL dose of GARDASIL on approximately 29-MAY-2008. the patient experienced hives all over her body within 24 hours of receiving her first dose of GARDASIL. The patient was recovered after taking BENADRYL. No lot number was provided. Therapy with GARDASIL was discontinued. Additional information has been requested.
Age: 25.0
Sex: F
Vaccine: HPV4
Symptoms: Influenza like illness
Clinical narrative: information has been received from a physician concerning an approximately 25 year old female who on "20-MAY-2009" was vaccinated, 0.5 ml, with the first dose of GARDASIL (route and lot number were not provided). Subsequently, the patient experienced flu like symptoms. The patient went to the emergency room for treatment however it was unknown if she was admitted into the hospital. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a medical assistant concerning a female patient who was vaccinated with the first dose of GARDASIL and had fainted. Unspecified medical attention had been sought. The patient had recovered. This is one of several reports received from the same source. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a medical assistant concerning a female patient who was vaccinated with the first dose of GARDASIL and fainted. Unspecified medical attention has been sought. The patient had recovered. This is one of several reports received from the same source. Additional information has been requested.
Age: 16.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Concussion, Contusion, Convulsion, Dizziness, Headache
Clinical narrative: My Daughter received the GARDASIL shot this morning, she fainted and had a seizure the episode lasted approx. 2 minutes. She is receiving medical care and under observation.
Age: 16.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Injection site pain, Injury, Loss of consciousness, Mydriasis, X-ray
Clinical narrative: My Daughter received the GARDASIL shot this morning, she fainted and had a seizure the episode lasted approx. 2 minutes. She is receiving medical care and under observation.
Age: 16.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Convulsion, Face and mouth X-ray, Syncope
Clinical narrative: My Daughter received the GARDASIL shot this morning, she fainted and had a seizure the episode lasted approx. 2 minutes. She is receiving medical care and under observation.
Age: 22.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Complex partial seizures, Computerised tomogram normal, Electroencephalogram, Grand mal convulsion, Impaired driving ability
Clinical narrative: DURING A ROUTINE PHYSICAL, I WAS GIVEN A TETANUS AND GARDASIL VACCINE SHOT.  APPROXIMATELY FIFTEEN AND A HALF HOURS AFTER THE FIRST INOCULATION OF THE VACCINE GARDASIL, I EXPERIENCED TWO ONSET GRAN MAL SEIZURES. SEIZURES OCCURED IN THE MORNING, WITHIN FOUR AND A HALF HOURS OF EACH OTHER. I WAS TRANSPORTED BY AMBULANCE AFTER BOTH EPISODES. AFTER FIRST SEIZURE, I WAS GIVEN A CT SCAN AND BLOOD WORK-UP. BOTH TESTS CAME BACK NEGATIVE. NO PRESCRIPTIONS WERE GIVEN. I WAS RELEASED FROM THE ER WITH INSTRUCTIONS TO FOLLOW UP WITH A NEUROLOGIST ASAP. AN HOUR AFTER RETURNING HOME, I EXPERIENCED A SECOND, GRAN MAL SEIZURE AND WAS TAKEN BY AMBULANCE BACK TO THE ER. I WAS GIVEN INTRAVENOUS DILANTIN, AND ADMITTED TO THE HOSPITAL WHERE I STAYED THURSDAY INTO FRIDAY. I WAS GIVEN MORE BLOOD WORK-UP, AN MRI, AND AN EEG. RESULTS ARE PENDING FOLLOW-UP VISITATION WITH THE NEUROLOGIST. IN THE HOSPITAL, I RECEIVED 300MG OF DILANTIN (PILL FORM), DAILY. ACCORDING TO THE TECHNICIAN AND NURSE, I WAS RELEASED FROM THE HOSPITAL BECAUSE THEIR INITIAL SCREENING OF MRI AND EEG DID NOT SHOW TUMOR, CLOTTING, OR BLEEDING IN THE BRAIN. THE NEUROLOGIST HAS PRESCRIBED 300MG OF DILANTIN (PILL FORM) TO BE TAKEN DAILY. I AM NOW RESTRICTED FROM DRIVING FOR A MINIMUM OF THREE MONTHS, PENDING MY RESPONSE TO MEDICATION. ALTHOUGH THE NEUROLOGIST HAS NOT SEEN THE MRI OR EEG RESULTS, I HAVE BEEN DIAGNOSED WITH HAVING COMPLEX-PARTIAL SEIZURE DISORDER. THE NEUROLOGIST IS RELUCTANT TO AFFIRM OR DENY GARDASIL AS A CATALYST TO GRAN MAL EVENTS.  6/16/09 Received hospital medical records for 6/11-6/12/2009. FINAL DX: partial complex seizures Records reveal patient experienced 2 tonoclonic seizures w/tongue biting on 6/10 lasting approx 3 min w/postictal period after.  Seen in outlying ER where w/u WNL & d/c to home.  Returned to ER after 2nd seizure, loaded w/antiseizure meds & transferred to higher level of care.  Neuro consult done & revealed pt had stereotype espisodes x 3 years. Tx w/antiseizure meds.  8/3/09 Received ICD9 codes: 780.39.
Age: 22.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Nuclear magnetic resonance imaging
Clinical narrative: DURING A ROUTINE PHYSICAL, I WAS GIVEN A TETANUS AND GARDASIL VACCINE SHOT.  APPROXIMATELY FIFTEEN AND A HALF HOURS AFTER THE FIRST INOCULATION OF THE VACCINE GARDASIL, I EXPERIENCED TWO ONSET GRAN MAL SEIZURES. SEIZURES OCCURED IN THE MORNING, WITHIN FOUR AND A HALF HOURS OF EACH OTHER. I WAS TRANSPORTED BY AMBULANCE AFTER BOTH EPISODES. AFTER FIRST SEIZURE, I WAS GIVEN A CT SCAN AND BLOOD WORK-UP. BOTH TESTS CAME BACK NEGATIVE. NO PRESCRIPTIONS WERE GIVEN. I WAS RELEASED FROM THE ER WITH INSTRUCTIONS TO FOLLOW UP WITH A NEUROLOGIST ASAP. AN HOUR AFTER RETURNING HOME, I EXPERIENCED A SECOND, GRAN MAL SEIZURE AND WAS TAKEN BY AMBULANCE BACK TO THE ER. I WAS GIVEN INTRAVENOUS DILANTIN, AND ADMITTED TO THE HOSPITAL WHERE I STAYED THURSDAY INTO FRIDAY. I WAS GIVEN MORE BLOOD WORK-UP, AN MRI, AND AN EEG. RESULTS ARE PENDING FOLLOW-UP VISITATION WITH THE NEUROLOGIST. IN THE HOSPITAL, I RECEIVED 300MG OF DILANTIN (PILL FORM), DAILY. ACCORDING TO THE TECHNICIAN AND NURSE, I WAS RELEASED FROM THE HOSPITAL BECAUSE THEIR INITIAL SCREENING OF MRI AND EEG DID NOT SHOW TUMOR, CLOTTING, OR BLEEDING IN THE BRAIN. THE NEUROLOGIST HAS PRESCRIBED 300MG OF DILANTIN (PILL FORM) TO BE TAKEN DAILY. I AM NOW RESTRICTED FROM DRIVING FOR A MINIMUM OF THREE MONTHS, PENDING MY RESPONSE TO MEDICATION. ALTHOUGH THE NEUROLOGIST HAS NOT SEEN THE MRI OR EEG RESULTS, I HAVE BEEN DIAGNOSED WITH HAVING COMPLEX-PARTIAL SEIZURE DISORDER. THE NEUROLOGIST IS RELUCTANT TO AFFIRM OR DENY GARDASIL AS A CATALYST TO GRAN MAL EVENTS.  6/16/09 Received hospital medical records for 6/11-6/12/2009. FINAL DX: partial complex seizures Records reveal patient experienced 2 tonoclonic seizures w/tongue biting on 6/10 lasting approx 3 min w/postictal period after.  Seen in outlying ER where w/u WNL & d/c to home.  Returned to ER after 2nd seizure, loaded w/antiseizure meds & transferred to higher level of care.  Neuro consult done & revealed pt had stereotype espisodes x 3 years. Tx w/antiseizure meds.  8/3/09 Received ICD9 codes: 780.39.
Age: 0.2
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Body temperature, Cellulitis, Culture stool positive, Dehydration, Diarrhoea
Clinical narrative: Information has been received from a medical assistant concerning a 9 weeks old female patient with no pertinent medical history and not known allergies, who on 28-MAY-2009 was vaccinated orally with a 2 mL dose of ROTATEQ (LOT # 663362/0039Y). On 28-MAY-2009, the patient concomitantly received DAPTACEL, ACTHIB, IPOL, and PREVNAR. On 03-JUN-2009, the patient's mother called to the physician's office because her child was having watery stools, up to 5 times a day, but no temperature. The patient was seen in the office on 4-JUN-2009 because of severe diarrhea and a rash on an unspecified area. On 04-JUN-2009, a stool culture was done in order to identify the presence of ova, parasites, rotavirus and c-diff, which was found to be positive for rotavirus. A hemoccult was done on 4-JUN-2009 and was also found positive for blood. On 05-JUN-2009 the patient was seen in the office for a recheck. The patient's rash was clearing up but the mother mentioned there was a spot on the right hand and left foot. The right hand was swollen and the left foot had a red spot. The patient was sent to the emergency room and was admitted to the hospital. The patient was diagnosed with cellulitis which was treated with IV fluids and IV CLEOCIN. On 7-JUN-2009 the patient was discharged from the hospital and on 8-JUN-2009 she was re-checked in the office for a post hospitalization visit. The patient had increased in weight by 8 ounces and was reported to be "so much better". The patient's hand was recovering and the spot on her foot went away. At the time of reporting the patient still was on CLEOCIN because of the cellulitis of the right hand. A follow-up visit was scheduled for July or August 2009. Follow-up information has been received from a physician concerning the patient with preauricular skin tags and no other medical problems. It was reported that the patient developed watery diarrhea and rash 5 to 6 days after administration of the first dose of ROTATEQ. On day two of illness, the patient became dehydrated, irritable and developed right hand cellulitis. It was reported that the patient was sent to the ER and admitted in the hospital for 2 days. At the time of reporting the patient had recovered. A lot check has been initiated. The reporting medical assistant considered that rotavirus positive, hemoccult positive for blood, watery stools, cellulitis, rash and red spot in the left foot were life threatening and required intervention to prevent other serious criteria. Additional information has been requested.
Age: 0.2
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Erythema, Gastroenteritis rotavirus, Haematochezia, Irritability, Occult blood positive
Clinical narrative: Information has been received from a medical assistant concerning a 9 weeks old female patient with no pertinent medical history and not known allergies, who on 28-MAY-2009 was vaccinated orally with a 2 mL dose of ROTATEQ (LOT # 663362/0039Y). On 28-MAY-2009, the patient concomitantly received DAPTACEL, ACTHIB, IPOL, and PREVNAR. On 03-JUN-2009, the patient's mother called to the physician's office because her child was having watery stools, up to 5 times a day, but no temperature. The patient was seen in the office on 4-JUN-2009 because of severe diarrhea and a rash on an unspecified area. On 04-JUN-2009, a stool culture was done in order to identify the presence of ova, parasites, rotavirus and c-diff, which was found to be positive for rotavirus. A hemoccult was done on 4-JUN-2009 and was also found positive for blood. On 05-JUN-2009 the patient was seen in the office for a recheck. The patient's rash was clearing up but the mother mentioned there was a spot on the right hand and left foot. The right hand was swollen and the left foot had a red spot. The patient was sent to the emergency room and was admitted to the hospital. The patient was diagnosed with cellulitis which was treated with IV fluids and IV CLEOCIN. On 7-JUN-2009 the patient was discharged from the hospital and on 8-JUN-2009 she was re-checked in the office for a post hospitalization visit. The patient had increased in weight by 8 ounces and was reported to be "so much better". The patient's hand was recovering and the spot on her foot went away. At the time of reporting the patient still was on CLEOCIN because of the cellulitis of the right hand. A follow-up visit was scheduled for July or August 2009. Follow-up information has been received from a physician concerning the patient with preauricular skin tags and no other medical problems. It was reported that the patient developed watery diarrhea and rash 5 to 6 days after administration of the first dose of ROTATEQ. On day two of illness, the patient became dehydrated, irritable and developed right hand cellulitis. It was reported that the patient was sent to the ER and admitted in the hospital for 2 days. At the time of reporting the patient had recovered. A lot check has been initiated. The reporting medical assistant considered that rotavirus positive, hemoccult positive for blood, watery stools, cellulitis, rash and red spot in the left foot were life threatening and required intervention to prevent other serious criteria. Additional information has been requested.
Age: 0.2
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Oedema peripheral, Rash
Clinical narrative: Information has been received from a medical assistant concerning a 9 weeks old female patient with no pertinent medical history and not known allergies, who on 28-MAY-2009 was vaccinated orally with a 2 mL dose of ROTATEQ (LOT # 663362/0039Y). On 28-MAY-2009, the patient concomitantly received DAPTACEL, ACTHIB, IPOL, and PREVNAR. On 03-JUN-2009, the patient's mother called to the physician's office because her child was having watery stools, up to 5 times a day, but no temperature. The patient was seen in the office on 4-JUN-2009 because of severe diarrhea and a rash on an unspecified area. On 04-JUN-2009, a stool culture was done in order to identify the presence of ova, parasites, rotavirus and c-diff, which was found to be positive for rotavirus. A hemoccult was done on 4-JUN-2009 and was also found positive for blood. On 05-JUN-2009 the patient was seen in the office for a recheck. The patient's rash was clearing up but the mother mentioned there was a spot on the right hand and left foot. The right hand was swollen and the left foot had a red spot. The patient was sent to the emergency room and was admitted to the hospital. The patient was diagnosed with cellulitis which was treated with IV fluids and IV CLEOCIN. On 7-JUN-2009 the patient was discharged from the hospital and on 8-JUN-2009 she was re-checked in the office for a post hospitalization visit. The patient had increased in weight by 8 ounces and was reported to be "so much better". The patient's hand was recovering and the spot on her foot went away. At the time of reporting the patient still was on CLEOCIN because of the cellulitis of the right hand. A follow-up visit was scheduled for July or August 2009. Follow-up information has been received from a physician concerning the patient with preauricular skin tags and no other medical problems. It was reported that the patient developed watery diarrhea and rash 5 to 6 days after administration of the first dose of ROTATEQ. On day two of illness, the patient became dehydrated, irritable and developed right hand cellulitis. It was reported that the patient was sent to the ER and admitted in the hospital for 2 days. At the time of reporting the patient had recovered. A lot check has been initiated. The reporting medical assistant considered that rotavirus positive, hemoccult positive for blood, watery stools, cellulitis, rash and red spot in the left foot were life threatening and required intervention to prevent other serious criteria. Additional information has been requested.
Age: 0.6
Sex: F
Vaccine: RV5
Symptoms: Dehydration, Gastroenteritis rotavirus
Clinical narrative: Information has been received from a physician concerning a 7 months old female with unknown drug allergies and unknown medical history who on 16-APR-2009 was vaccinated with the second dose of ROTATEQ (lot# unavailable).  On 26-MAY-2009 the patient was hospitalized after receiving the second dose of ROTATEQ because of dehydration due to Rotavirus gastroenteritis.  The hospital demographics were unspecified.  At the time of the report, the patient had recovered.  The health care professional contacted during telephone follow-up could not supply the following information: patient name, date of birth, dates of vaccination, dose number (if applicable), lot number, date of event, recovery status, hospital name (if applicable), healthcare provider name and contact information.  Additional information has been requested.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Amyotrophic lateral sclerosis
Clinical narrative: Information has been received from a hospice nurse concerning a 16 years old female with unknown drug allergies and unknown medical history who was vaccinated with the first dose of GARDASIL. Subsequently the patient was diagnosed with Amyotrophic Lateral Sclerosis (ALS) shortly after receiving the first dose of GARDASIL. The nurse learned of the patient's experience when her family called seeking hospice care for her. The family did mention that the first dose of GARDASIL caused that to the patient. Unspecified medical attention was sought. It was unspecified if laboratory studies were performed. At the time of the report, the patient had not recovered. The Amyotrophic Lateral Sclerosis was considered to be disabling. In follow-up with the representative, it was learned that no contact information is available. No further information is available.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Abortion induced, Abortion spontaneous, Drug exposure during pregnancy, Pregnancy test positive
Clinical narrative: Information has been received from a health professional for the pregnancy registry for GARDASIL concerning a female with a history of atrial septal defect repair at age seven, who on 07-OCT-2007 was vaccinated with GARDASIL (lot # 656371/0181U). On 7-Jan-2008 the patient was vaccinated with her second dose of GARDASIL (lot # 655322/0092U). On 06-May-2008 the patient received her third dose of GARDASIL (lot # 655322/0092U). It was reported that the patient was found to be pregnant later the same day the last vaccination was given. A laboratory report was received in the office of a positive pregnancy test from the hospital the same day the last dose of vaccine was administered. Patient did not report the pregnancy. No problems were reported. Follow-up information has been received from a certified medical assistant who said that the patient was actually not pregnant at the time of the shot. She was not specific about which dose she was talking about. She reported that they found out that the patient lost the pregnancy a few days before her shot and very early in the pregnancy. She was not sure if it was an elective termination or a spontaneous abortion (SAB). Upon internal review, elective termination or a spontaneous abortion (SAB) was determined to be an other important medical event.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Alopecia areata, Alopecia universalis, Dermatologic examination
Clinical narrative: Developed Alopecia Areata Universalis beginning three days after receiving third GARDASIL booster, Tetanus with Pertussis injection, and Flu vaccine.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Alpha 1 foetoprotein decreased, Blood cholesterol increased, Blood glucose increased, Blood test abnormal, Carbon dioxide decreased
Clinical narrative: I received the vaccine and a month later was diagnosed with Grovers disease which is a rash on the back and chest. Seems to me it very coincidental. The only relief that I get is from the drug SORIATANE which may have other adverse effects.  8/6/09 Dermatology consultant records received DOS 7/25/06 to 3/13/09. Assessment: Transient Acantholytic Dermatosis (Grover's Disease). Patient presents with itchy rash on chest and back - folliculitis. Blackheads. Scars on face, scar revision surgery performed.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Full blood count, High density lipoprotein normal, Low density lipoprotein normal, Mean cell haemoglobin, Mean cell volume increased
Clinical narrative: I received the vaccine and a month later was diagnosed with Grovers disease which is a rash on the back and chest. Seems to me it very coincidental. The only relief that I get is from the drug SORIATANE which may have other adverse effects.  8/6/09 Dermatology consultant records received DOS 7/25/06 to 3/13/09. Assessment: Transient Acantholytic Dermatosis (Grover's Disease). Patient presents with itchy rash on chest and back - folliculitis. Blackheads. Scars on face, scar revision surgery performed.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Metabolic function test, Neutrophil count increased, Rash pruritic, Transient acantholytic dermatosis, Transient acantholytic dermatosis
Clinical narrative: I received the vaccine and a month later was diagnosed with Grovers disease which is a rash on the back and chest. Seems to me it very coincidental. The only relief that I get is from the drug SORIATANE which may have other adverse effects.  8/6/09 Dermatology consultant records received DOS 7/25/06 to 3/13/09. Assessment: Transient Acantholytic Dermatosis (Grover's Disease). Patient presents with itchy rash on chest and back - folliculitis. Blackheads. Scars on face, scar revision surgery performed.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, HIBV, IPV, MMR
Symptoms: Erythema, Feeling hot, Rash pruritic
Clinical narrative: Pt was seen 6/8/09 for 5 year WCC and received MMR, VZV, PV, DTaP, Hib and Hep A. He woke up this a.m. c/o itchy red rash on (L) upper thigh which became red and warm.
Age: 6.0
Sex: M
Vaccine: DTAPIPV, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: 6/3/09 office visit:  Red, warm area on left thigh, painful (to touch),
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Syncope
Clinical narrative: Light headedness, dizziness since vaccine series completed one year ago. Fainted 6/4/09.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Patient fainted
Age: 22.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Hypoaesthesia, Hypoaesthesia facial, Paraesthesia
Clinical narrative: Tingling & numbness of the Rt fingers & right arm & nose 2 weeks seen by 5.26.09. No symptoms after 6-12-09
Age: 18.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Feeling hot, Immediate post-injection reaction, Oedema peripheral, Pain in extremity
Clinical narrative: Immediately after receiving vaccine, right arm became very sore.  Redness developed at 11:00 PM.  Warm to touch.  Area is very swollen.
Age: 52.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Injected limb mobility decreased, Injection site pain, Pain, Pyrexia
Clinical narrative: Severe pain at the injection, Limited movement. Fever, chills, body aches for 2 days.
Age: 59.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Severe tenderness and swelling at site. Lasted for 2 weeks. Required medication for several days - ADVIL
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site urticaria, Injection site warmth
Clinical narrative: 6/3/09 Came in for office visit - Urticaria on Rt thigh, warm to touch, non-tender.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Erythema, Induration, Skin warm, Tenderness
Clinical narrative: 6/10/09 office visit- firm, red, tender, warm area on (L) thigh.
Age: 32.0
Sex: F
Vaccine: TDAP
Symptoms: Hypersensitivity, Injection site swelling, Pruritus, Rash
Clinical narrative: Allergic reaction rash, swollen area around injection site. Itchy hand etc. Rash is 40mm in length.
Age: 0.5
Sex: F
Vaccine: DTAPIPVHIB, PNC, RV5
Symptoms: Culture negative, Dehydration, Dermatitis exfoliative
Clinical narrative: EXFOLIATIVE ERYTHRODERMA - required hospitalization due to dehydration. Treated with steroids for over 2 wks.  6/17/09 Medical record received DOS 6/1/09. Assessment: Exfoliating erythroderma, dehydration. Patient presents with pruritic, raised, macular rash over entire body except for hands and feet. Irritable. Rash is scaly and began to desquamate. Excoriations. Pain. Not sleeping well. Decreased food and fluid intake and fewer wet diapers.  To admit to hospital.  6/22/09 ICD-9 Codes received DOS 6/1/09: 69589, 27651
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Mom described area on (R) leg is approximately 1 inch from injection site. 3 inches wide and 2 inches tall and red and hot to touch. Per mom spoke with RN on call Sunday 6-7-09 - Spoke with another RN on Monday 6-8-09 and area more red but child had just come in from outside playing
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: Vaccine given on 6/5/09. On 6/7/09 area on left leg - raised, warm, measuring at 6 x 8 cm.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site haematoma, Injection site warmth
Clinical narrative: Patient has a quarter-sized red area at the injection site that is warm to touch. There is also significant bruising in a 3-4 inch area surrounding the red area. Physician advised Diphenhydramine and to apply ice.
Age: 0.3
Sex: F
Vaccine: DTAPIPVHIB, PNC, RV1
Symptoms: Body temperature increased, Injection site erythema, Injection site induration, Irritability, Somnolence
Clinical narrative: Received PCV-7 in (R) thigh and PENTACEL (DTaP-IPV-Hib) in (L) thigh on June 5 in PM. Increased sleepiness rest of June 5, 2009. On 6-6-09 noticed hard red area on thighs and low grade temp and fussiness. Diffuse visit PM 6-8-09. had less fussiness. (R) thigh 1/2" induration with redness center, (L) thigh, 1/4" induration with slight pink center.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Cellulitis, Injection site erythema, Injection site rash
Clinical narrative: Child has a 6cm x 3cm erythematous rash on her (R) upper anterior thigh Laterally & anteriorly is the injection site.
Age: 45.0
Sex: M
Vaccine: ANTH, HEP, TYP
Symptoms: Attention deficit/hyperactivity disorder, Chills, Confusional state, Dizziness, Fatigue
Clinical narrative: Member woke during night with chills, painful skin irritation. Full body aches, light-headedness, exhaustion, lack of focus, periods of mild confusion, redness and swelling at injection site on left arm.
Age: 45.0
Sex: M
Vaccine: ANTH, HEP, TYP
Symptoms: Injection site erythema, Injection site swelling, Pain, Skin irritation
Clinical narrative: Member woke during night with chills, painful skin irritation. Full body aches, light-headedness, exhaustion, lack of focus, periods of mild confusion, redness and swelling at injection site on left arm.
Age: 37.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Skin warm
Clinical narrative: Redness 7cm x 5 1/2 cm warm to touch.
Age: 25.0
Sex: F
Vaccine: ANTH, SMALL
Symptoms: Erythema, Pain
Clinical narrative: Spreading, redness, pain
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Pharyngeal oedema, Urticaria
Clinical narrative: Within 1/2 hr. - hives and swelling throat, took BENADRYL - 50 mg, then another 25 mg 6 hrs. later. Ok next day.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: (L) leg red and swollen 35 mm X 35 mm
Age: 0.6
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Pyrexia, Rash erythematous, Rash maculo-papular
Clinical narrative: Child received PENTACEL, PREVENAR, GENHEVAC B, and ROTATEQ on 5/4/09. On 5/5/09 child dev'd factile fever and red maculopapular rash on chest/back/face/abdomen which subsequently resolved.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Right deltoid, red, warm to touch. Swollen, raised, 6cm x 3cm.
Age: 45.0
Sex: M
Vaccine: ANTH, HEP, TYP
Symptoms: Chest discomfort, Dyspnoea, Feeling cold, Headache
Clinical narrative: Frontal headache "head pounding" chest tightness and some shortness of breath (although speaking normally) and "feeling cold" - visibly shivering. vs normal P-76-R-16 PERRLA, Lungs CTA bilat, no wheezing or & breath sounds, heart RRR, No rash to fore, neck, arm, chest.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Full blood count, Hypersensitivity, Injection site erythema, Injection site swelling, Lip swelling
Clinical narrative: Pt received Immunisation and then in about 2 hrs developed so many hives on face, neck, arm, abdomen- had swollen upper lip. Was seen at emergency room- was given Benadryl- pt started resolving hives and rash in a short time swelling of lips improved only pt had swelling and redness on left thigh region- no difficulty breathing.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Lymphocyte percentage, Neutrophil count increased, Rash, Urticaria
Clinical narrative: Pt received Immunisation and then in about 2 hrs developed so many hives on face, neck, arm, abdomen- had swollen upper lip. Was seen at emergency room- was given Benadryl- pt started resolving hives and rash in a short time swelling of lips improved only pt had swelling and redness on left thigh region- no difficulty breathing.
Age: 14.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, VARCEL
Symptoms: Cellulitis, Erythema, Hypoaesthesia, Injection site erythema, Injection site swelling
Clinical narrative: Pt was given MENACTRA - Vaccine given 5/28/09 redness 5/29 then seen 5/31 in ER Hosp. for right arm swelling shoulder to hand - Numb/tingling hand -Vaccine site 3" redness - Dx cellulitis - RX KEFLEX - Symptoms improved over days 6/4 itchy dic - ed KEFLEX
Age: 14.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, VARCEL
Symptoms: Paraesthesia, Pruritus, Swelling
Clinical narrative: Pt was given MENACTRA - Vaccine given 5/28/09 redness 5/29 then seen 5/31 in ER Hosp. for right arm swelling shoulder to hand - Numb/tingling hand -Vaccine site 3" redness - Dx cellulitis - RX KEFLEX - Symptoms improved over days 6/4 itchy dic - ed KEFLEX
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: A developed shingles like rash in left T8-9 dermatoma, 2 days after receiving the vaccine.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Culture negative, Rash, Streptococcal identification test negative
Clinical narrative: Rash 10 days post vaccination seen in office for rash.  ATARAX Rx.
Age: 39.0
Sex: F
Vaccine: MMR
Symptoms: Allergy to vaccine, Axillary pain, Discomfort, Erythema, Injection site discomfort
Clinical narrative: 6-2-09 Rcvd  MMR SubQ @ Health Dept.  6-11-09 Pt. returned to HD.  Exhibits approx 10 mm by 15 mm reddened & inflamed area upper outer aspect of Left ARM. 2nd smaller reddened area 5mm by 5mm in same arm.   Area itches & has some discomfort. Some discomfort in left axillary region as well.  6-11-09 visit to ER.  Dr states "allergic reaction to vaccine".  6/29/09 Medical records received DOS 8/07/08 to 4/08/09 Assessment: Cephalgia and Syncope. Patient presents with abdominal and pelvic pain. Menorrhagia. Later "passed out/blacked" out while driving. Plantar warts - cryosurgery, electrosurgery. Syncope, cough, cephalgia, emesis, fever. Nasal congestion and sinus pain. Serous effusion - ears. URI.  HPV Dose #1 - 4/11/08, HPV Dose #2 - 6/13/08, HPV Dose #3 - 1/9/09
Age: 39.0
Sex: F
Vaccine: MMR
Symptoms: Injection site erythema, Injection site inflammation, Injection site pruritus
Clinical narrative: 6-2-09 Rcvd  MMR SubQ @ Health Dept.  6-11-09 Pt. returned to HD.  Exhibits approx 10 mm by 15 mm reddened & inflamed area upper outer aspect of Left ARM. 2nd smaller reddened area 5mm by 5mm in same arm.   Area itches & has some discomfort. Some discomfort in left axillary region as well.  6-11-09 visit to ER.  Dr states "allergic reaction to vaccine".  6/29/09 Medical records received DOS 8/07/08 to 4/08/09 Assessment: Cephalgia and Syncope. Patient presents with abdominal and pelvic pain. Menorrhagia. Later "passed out/blacked" out while driving. Plantar warts - cryosurgery, electrosurgery. Syncope, cough, cephalgia, emesis, fever. Nasal congestion and sinus pain. Serous effusion - ears. URI.  HPV Dose #1 - 4/11/08, HPV Dose #2 - 6/13/08, HPV Dose #3 - 1/9/09
Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Chills, Headache, Influenza serology negative, Oropharyngeal pain, Pain
Clinical narrative: Fever, chills, headache, sore throat achy arms and legs.
Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Pyrexia
Clinical narrative: Fever, chills, headache, sore throat achy arms and legs.
Age: 14.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Fatigue
Clinical narrative: Fatigue X 2 days
Age: 0.1
Sex: M
Vaccine: DTAPIPVHIB, HEP, RV1
Symptoms: Faeces discoloured, Haematochezia, Irritability, Mucous stools, Occult blood positive
Clinical narrative: Increased irritability with green/mucus colored stool with presence of blood, which was Hemacult + and in office, pt improving.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Body temperature increased, Dizziness
Clinical narrative: Woke up at 2 AM on 6/9/09 with temp of 101.4 & feeling dizzy.  As of 8 am was feeling better, temp gone.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Allergy test positive, Urticaria
Clinical narrative: Hives occurred 5 to 7 days after shingles vaccine on sides of neck and other places shingles would appear.  Was taking NITROFURANTOIN MACROCRYSTAL for 3 months prior with no issues.  Stopped taking this "MACROBID".  Symptoms eased up.  But still getting the hives in the evening; they are gone by AM.
Age: 17.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Activities of daily living impaired, Axillary pain, Body temperature increased, Chills, Headache
Clinical narrative: Received vaccines 4/21/09. That night he had chills and temp of 100 degrees. Stayed home from school on 4/22 AM. Had been treated with MOTRIN. 4/23/09 c/o bad headache and soreness R underarm. 4/27/09 TC to mom - she report s/s resolved now.
Age: 47.0
Sex: M
Vaccine: FLU3
Symptoms: No adverse event
Clinical narrative: None stated
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Large 9 cm red area with 3x4 cm raised x 6cm area. No drainage - warm to touch. Doctor advised Benadryl cream to area with ice packs. If no better in 2 days return to office. Pt reported to office 6/9/09.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Local reaction, Pruritus, Swelling
Clinical narrative: Localized itching, erythema, and swelling about 2 days after injection. Improved with BENADRYL administration,  no pain/tenderness.
Age: 75.0
Sex: F
Vaccine: TD
Symptoms: Erythema, Swelling, Tenderness
Clinical narrative: Tenderness, swelling, erythema. No treatment necessary.
Sex: F
Vaccine: TD
Symptoms: Back pain, Chills, Dizziness, Fatigue, Hyperhidrosis
Clinical narrative: Pain in arm neck back, chills fever sweating. Dizzy, nausea, fatigue, muscle weakness.
Sex: F
Vaccine: TD
Symptoms: Muscular weakness, Nausea, Neck pain, Pain in extremity, Pyrexia
Clinical narrative: Pain in arm neck back, chills fever sweating. Dizzy, nausea, fatigue, muscle weakness.
Age: 43.0
Sex: M
Vaccine: HEP, HEPA
Symptoms: Unevaluable event
Clinical narrative: None stated
Age: 12.0
Sex: M
Vaccine: MNQ, VARCEL
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Had IZs 6/9/09, on 6/11/09 MOC called, stated pt. had red area back of rt. arm, size 1"x2", hurts a little, not itchy
Age: 38.0
Sex: F
Vaccine: HEPA
Symptoms: Unevaluable event
Clinical narrative: None stated
Sex: F
Vaccine: UNK
Symptoms: No adverse event
Clinical narrative: No adverse reactions previously
Age: 1.3
Sex: M
Vaccine: HIBV, PNC
Symptoms: Convulsion, Pyrexia
Clinical narrative: Patient had fever and a seizure afterwards.  Was taken to the ER at medical center.
Age: 83.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Pt came in and stated that 2 months after ZOSTAVAX, she was dx with shingles. Pt had never had shingles disease before.
Age: 51.0
Sex: F
Vaccine: UNK
Symptoms: Fatigue, Injected limb mobility decreased, Neck pain, Oedema peripheral, Pain in extremity
Clinical narrative: Left arm edema, tenderness, fatigue onset 15 hours after injection. Felt arm pain with movement 15 hours after injection. Unable to move arm without pain. No fever, chills, no erythema at injection site. Ache into neck.
Age: 51.0
Sex: F
Vaccine: UNK
Symptoms: Tenderness
Clinical narrative: Left arm edema, tenderness, fatigue onset 15 hours after injection. Felt arm pain with movement 15 hours after injection. Unable to move arm without pain. No fever, chills, no erythema at injection site. Ache into neck.
Sex: U
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: UTD